Editing liver tumours

@article{Colnot2013EditingLT,
  title={Editing liver tumours},
  author={S. Colnot and P. Fortes},
  journal={Gut},
  year={2013},
  volume={63},
  pages={709 - 710}
}
  • S. Colnot, P. Fortes
  • Published 2013
  • Biology, Medicine
  • Gut
  • There is an urgent need for new therapeutic options for hepatocellular carcinoma (HCC), which is currently the third cause of cancer-related death worldwide.1 HCC develops most frequently in the setting of cirrhosis. This premalignant condition occurs as a consequence of chronic liver disease, mainly as a result of hepatitis B and C viral infection, alcohol abuse and obesity. The poor efficacy of many antiproliferative agents against HCC is due in part to the inefficient drug delivery and… CONTINUE READING
    1 Citations

    References

    SHOWING 1-10 OF 11 REFERENCES
    Medical therapies for hepatocellular carcinoma: a critical view of the evidence
    • 249
    Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
    • 290
    MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
    • 112
    • PDF
    Altered adenosine-to-inosine RNA editing in human cancer.
    • 261
    • PDF
    A-to-I RNA editing: the "ADAR" side of human cancer.
    • 70